The Effect of Vildagliptin on Endothelium-dependent Vasodilatation. A Double Blind Cross-over Study in Type 2 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Vildagliptin (Primary) ; Acarbose
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms VILD1
- 16 Sep 2011 Substudy results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Jul 2011 Results published in the Diabetes Care.
- 04 Nov 2010 Actual end date (October 2010) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History